NGM Biopharmaceuticals, Inc. Operating Income 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. operating income from 2019 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| NGM Biopharmaceuticals, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-151 |
| 2022 | $-166 |
| 2021 | $-121 |
| 2020 | $-104 |
| 2019 | $-49 |
| 2018 | $-4 |
| 2017 | $-17 |
| NGM Biopharmaceuticals, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-30 |
| 2023-09-30 | $-31 |
| 2023-06-30 | $-41 |
| 2023-03-31 | $-50 |
| 2022-12-31 | $-38 |
| 2022-09-30 | $-48 |
| 2022-06-30 | $-47 |
| 2022-03-31 | $-33 |
| 2021-12-31 | $-27 |
| 2021-09-30 | $-29 |
| 2021-06-30 | $-37 |
| 2021-03-31 | $-28 |
| 2020-12-31 | $-28 |
| 2020-09-30 | $-30 |
| 2020-06-30 | $-26 |
| 2020-03-31 | $-21 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-13 |
| 2019-06-30 | $-10 |
| 2019-03-31 | $-9 |
| 2018-12-31 | $13 |
| 2018-09-30 | $-8 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-5 |
